The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

New phase 1_2 trial NCT07353645 posted by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School: "KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer". New trial on a phase 1_2 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 146 days ago.

NextMap clinical development and translational medicine stakeholders on the sponsor, confirm no colleague is mid-conversation, then draft evidence-based outreach.